Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Cancer Immunotherapy Market Expected To Grow In Terms Of Size?

The cancer immunotherapy market has experienced swift expansion in the previous few years. It is projected to increase from $110.91 billion in 2024 to $124.09 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. The historical period’s development is due to the growing incidence of cancer, a shift from traditional therapy to immunotherapy, an intensification in research and development activities aimed at targeted diseases, improved efficiency and precision of contemporary therapies, and an increasing understanding of traditional cancer treatments’ limitations.

Forecasts suggest that the cancer immunotherapy market is set to experience substantial expansion in the upcoming years, reaching a value of $189.5 billion by 2029, with a CAGR of 11.2%. The expected growth in this period is a result of a number of factors including the surge in approval of innovative immunotherapies for cancer, growing interest in personalized medicine, increased rates of cancer detection, escalating investment in clinical trials geared towards advanced treatments, as well as heightened awareness about cancer immunotherapy. Key trends projected for the forecast period include the rise of adoptive cell therapies like car-t cells, increased exploration of oncolytic viruses in cancer immunotherapy, the development of tailored cancer vaccines, the application of artificial intelligence in immunotherapy research, and a growing focus on real-world evidence and patient outcomes when making treatment decisions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp

What Are The Primary Factors Supporting The Cancer Immunotherapy Market Expansion?

The anticipated increase in cancer occurrence is predicted to drive the cancer immunotherapy market. The rise in global cancer incidents can be attributed to factors such as tobacco use, alcohol, obesity, sedentary living, and environmental influences. This projected rise in cancer patients is likely to heighten the need for cancer immunotherapies, with patients more inclined to seek medical therapies that ensure higher recovery rates and minimal pain. For instance, the European Union Science Hub, a Belgium-based division of the European Commission’s Joint Research Centre, reported in October 2023 that new cases of cancer witnessed a 2.3% rise over the last two years, hitting 2.74 million in 2022. Likewise, cancer mortality rates also increased by 2.4% over the same period. Consequently, this upward trend in cancer occurrences is slated to fuel demand for cancer immunotherapy for the foreseeable future.

Which Segmentation Categories Are Highlighted In The Cancer Immunotherapy Market Analysis?

The cancer immunotherapy market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

Which Market Trends Are Expected To Define The Future Of The Cancer Immunotherapy Market?

In the cancer immunotherapy market, the rising trend is the utilization of advanced technologies. Numerous new technologies and therapies have emerged that aid the immune system in detecting and combating tumors with varying treatments and technologies, such as immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy. These advancements have the potential to revolutionize cancer treatment protocols and impact cure rates positively. For example, in October 2022, AstraZeneca plc, a biotechnology firm based in the UK, confirmed that it had gained approval for its Capivasertib, used in tandem with Faslodex. This specific drug, a cancer immunotherapeutic, has been created for treating breast cancer and has proven effective in cases of recurrence and progression post-endocrine therapy, specifically in locally advanced or metastatic breast cancer showing low to negative human epidermal growth factor receptor 2 (HER2).

Which Organizations Are At The Forefront Of The Cancer Immunotherapy Market?

Major companies operating in the cancer immunotherapy market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, 3D Signatures Inc., Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, Kura Oncology Inc., MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Pulse Biosciences Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Cancer Immunotherapy Market?

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=6768&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model